VNDA · Vanda Pharmaceuticals Inc. · Proposed Sales
$4.01
+0.19 (+4.84%)
At close · Nov 9
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$230.99M
Shares
60.47M
Volume · Nov 9
288.68K
Avg daily vol (3M)
1.06M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-03-02 | Gunther Birznieks | SVP, Business Development | 42,431 | 2026-03-02 | Merrill Lynch |
| 2026-03-02 | Joakim Wijkstrom | SVP, Chief Marketing Officer | 30,800 | 2026-03-02 | Merrill Lynch |
| 2026-03-02 | Kevin Moran | SVP, CFO & Treasurer | 42,442 | 2026-03-02 | Merrill Lynch |
| 2026-03-02 | Mihael H. Polymeropoulos | Officer, Chairman of the Board | 156,235 | 2026-03-02 | Merrill Lynch |
| 2026-03-02 | Timothy Williams | SVP & General Counsel | 42,434 | 2026-03-02 | Merrill Lynch |
| 2026-02-23 | Honore Tage | Director | 30,000 | 2026-02-23 | Merrill Lynch |
| 2025-06-13 | Mitchell Stephen Ray | Director | 7,000 | 2025-06-13 | Merrill Lynch |
| 2024-11-14 | Mitchell Stephen Ray | Director | 5,000 | 2024-11-14 | Merrill Lynch |
| 2024-07-29 | Moran Kevin Patrick | Officer | 2,251 | 2024-07-29 | Merrill Lynch |
| 2024-03-04 | Wijkstrom Joakim | Officer | 30,300 | 2024-03-04 | Merrill Lynch |
| 2024-03-04 | Polymeropoulos Mihael Hristos | Officer, Director, Chairman of the Board | 101,250 | 2024-03-04 | Merrill Lynch |
| 2024-03-04 | Moran Kevin Patrick | Officer | 27,689 | 2024-03-04 | Merrill Lynch |
| 2024-03-04 | Williams Timothy | Officer | 32,025 | 2024-03-04 | Merrill Lynch |
| 2024-03-04 | Birznieks Gunther | Officer | 32,025 | 2024-03-04 | Merrill Lynch |
| 2023-08-21 | Wijkstrom Joakim | Officer | 3,724 | 2023-08-21 | Merrill Lynch |
| 2023-08-10 | Mitchell Stephen Ray | Director | 6,500 | 2023-08-10 | Merrill Lynch |
| 2023-07-28 | Moran Kevin Patrick | Officer | 2,212 | 2023-07-28 | Merrill Lynch |
| 2023-06-15 | Moran Kevin Patrick | Officer | 16,000 | 2023-06-15 | Merrill Lynch |
| 2023-06-13 | Williams Timothy | Officer | 14,600 | 2023-06-13 | Merrill Lynch |
Showing 1–19 of 19 filings
Key facts
CIK
1347178
CUSIP
921659108
13F (30d)
68 filings
52 filers
Visit website
Investor relations